Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02863055Phase 2Terminated
Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma
Malignant Pleural Mesothelioma
PrincipalinvestigatorStart date: 2018-02-04
NCT02497053Phase 2Unknown
Four Versus Six Cycles of Pemetrexed/Platinum for MPM
Malignant Pleural Mesothelioma
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Ain Shams University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Enrique Estrada Lobato, M.D.

National Institute of Cancerología

Moderately Similar
1 trials

Shared therapeutic areas:

Malignant Pleural Mesothelioma
Similarity Score30%

Elena Arechaga Ocampo, PhD.

National Institute of Cancerología

Moderately Similar
1 trials

Shared therapeutic areas:

Malignant Pleural Mesothelioma
Similarity Score30%

Katherine Kim, MD

Ikena Oncology

Moderately Similar
2 trials

Shared therapeutic areas:

Malignant Pleural Mesothelioma
Similarity Score30%

Miguel Angel Ríos Trejo, M.D.

National Institute of Cancerología

Moderately Similar
1 trials

Shared therapeutic areas:

Malignant Pleural Mesothelioma
Similarity Score30%

Luisa Geraldine Villanueva Rodríguez, M.D

National Institute of Canerología

Moderately Similar
1 trials

Shared therapeutic areas:

Malignant Pleural Mesothelioma
Similarity Score30%

Anne S. Tsao, MD

M.D. Anderson Cancer Center

Moderately Similar
5 trials

Shared therapeutic areas:

Malignant Pleural Mesothelioma
Similarity Score30%

Zwi N Berneman, MD, PhD

Antwerp University Hospital, Division of Hematology and Center for Cell Therapy and Regenerative Medicine

Moderately Similar
4 trials

Shared therapeutic areas:

Malignant Pleural Mesothelioma
Similarity Score30%

Jermaine Coward

Integrated Haematology and Oncology Network

Moderately Similar
2 trials

Shared therapeutic areas:

Malignant Pleural Mesothelioma
Similarity Score30%

Michael Offin, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
5 trials

Shared therapeutic areas:

Malignant Pleural Mesothelioma
Similarity Score30%

Lee Krug

Memorial Sloan Kettering Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Malignant Pleural Mesothelioma
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02863055Phase 2PrincipalInvestigator

Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

Malignant Pleural Mesothelioma
Terminated
NCT02497053Phase 2PrincipalInvestigator

Four Versus Six Cycles of Pemetrexed/Platinum for MPM

Malignant Pleural Mesothelioma
Unknown

All 2 trials loaded